Procter & Gamble Co. — Form 10-K Summary
Reporting period: Fiscal year ended June 30, 2023, filed August 4, 2023. The request references “2022 Q4,” but the provided filing is an annual report for fiscal 2023 rather than a quarterly filing.
Business Context
P&G is a branded consumer packaged-goods company operating in approximately 70 countries and selling in approximately 180 countries and territories. Its five reportable segments are Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. Walmart and its affiliates represented approximately 15% of annual sales; the ten largest customers represented 40%.
The company had approximately 107,000 employees as of June 30, 2023. Management’s strategy emphasizes product superiority, innovation, productivity, digital capabilities, supply-chain resilience, sustainability, and balanced top- and bottom-line growth.
Financial Performance
| Metric | FY2023 | FY2022 | Change |
|---|---|---|---|
| Net sales | $82.006 billion | $80.187 billion | 2% |
| Organic sales growth | 7% | Not clearly provided in the filing excerpt | — |
| Operating income | $18.134 billion | $17.813 billion | 2% |
| Operating margin | 22.1% | 22.2% | Down 10 bps |
| Net earnings | $14.738 billion | $14.793 billion | Down modestly |
| Net earnings attributable to P&G | $14.653 billion | $14.742 billion | Down 1% |
| Diluted EPS | $5.90 | $5.81 | Up 2% |
| Gross margin | 47.9% | 47.4% | Up 50 bps |
| Effective tax rate | 19.7% | 17.8% | Up 190 bps |
| Operating cash flow | $16.848 billion | $16.723 billion | Up 1% |
| Adjusted free cash flow | $14.011 billion | $13.792 billion | Up 2% |
| Adjusted free cash flow productivity | 95% | 93% | Up 2 percentage points |
Reported sales growth reflected 9% pricing and 1% favorable mix, offset by a 5% foreign-exchange headwind and a 3% unit-volume decline. Foreign exchange reduced net earnings by approximately $1.4 billion.
Segment Results
| Segment | FY2023 Sales | Sales Change | Net Earnings | Earnings Change |
|---|---|---|---|---|
| Beauty | $15.008 billion | 2% | $3.178 billion | 1% |
| Grooming | $6.419 billion | Down 3% | $1.461 billion | Down 2% |
| Health Care | $11.226 billion | 4% | $2.125 billion | 6% |
| Fabric & Home Care | $28.371 billion | 3% | $4.828 billion | 10% |
| Baby, Feminine & Family Care | $20.217 billion | 2% | $3.545 billion | 9% |
Health Care and Fabric & Home Care delivered the strongest reported earnings growth. Grooming sales declined primarily because of foreign exchange, lower volume, and unfavorable mix, including weaker appliance sales.
Cash Flow, Debt and Liquidity
- Cash and cash equivalents were $8.246 billion at June 30, 2023, compared with $7.214 billion a year earlier.
- Total debt was approximately $34.6 billion, including $10.229 billion due within one year and $24.378 billion of long-term debt.
- Capital expenditures were $3.062 billion, or 3.7% of sales. Acquisitions used $765 million, primarily for a Beauty acquisition.
- Dividends paid were $8.999 billion, and share repurchases totaled $7.353 billion. The company expected to repurchase $7.4 billion to $8.0 billion of shares in fiscal 2023 and completed $7.4 billion of planned repurchases.
- Current liabilities exceeded current assets by $13.1 billion, largely because of short-term borrowings under the commercial paper program. Management expects operating cash flow and capital-market access to support liquidity needs.
- P&G maintained $8.0 billion of undrawn bank credit facilities. Credit ratings were Moody’s P-1/Aa3 and S&P A-1+/AA-, all with stable outlooks.
- Approximately $6 billion payable to suppliers participating in the supply-chain-finance program was included in accounts payable at June 30, 2023. The filing states that approximately 3% of global suppliers participated.
Material Changes Versus the Prior Period
- Pricing increased materially, but unit volume declined 3%, indicating that reported sales growth was primarily price-driven.
- Gross margin improved 50 basis points from pricing and manufacturing productivity savings, but operating margin declined 10 basis points because SG&A increased faster than sales.
- SG&A increased 4% to $21.1 billion; wage inflation, other overhead costs, and foreign-exchange transaction charges offset marketing productivity savings.
- Interest expense increased to $756 million from $439 million because of higher rates and higher short-term debt. Interest income increased to $307 million from $51 million.
- The effective tax rate rose to 19.7% from 17.8%, primarily due to lower excess tax benefits, uncertain-tax-position impacts, and lower foreign-derived intangible income deductions.
- Restructuring charges increased to $329 million from $253 million. The restructuring reserve was $174 million at June 30, 2023.
- Foreign-currency translation loss in other comprehensive income was $71 million, compared with a $1.450 billion loss in fiscal 2022.
Guidance, Outlook and Management Commentary
Management’s long-term growth algorithm targets organic sales growth above category and geographic market growth, core EPS growth in the mid-to-high single digits, and adjusted free cash flow productivity of at least 90%. The filing does not provide a specific fiscal 2024 earnings or sales forecast in the supplied text.
Management expects to continue using operating cash flow, dividends, share repurchases, acquisitions, productivity programs, and debt financing as appropriate to support shareholder returns and portfolio investments. Incremental cash-flow benefits from extended supplier payment terms may increase at a slower rate in fiscal 2024.
Key Risks, Contingencies and Unusual Items
- Foreign-exchange volatility, inflation, commodity and transportation costs, pricing actions, and potential volume elasticity may pressure sales and margins.
- The Russia-Ukraine war continues to affect operations. Russia represented approximately 2% of fiscal 2023 consolidated sales and earnings; Ukraine represented less than 1%. P&G reduced its Russian portfolio, stopped new capital investment, and suspended media, advertising, and promotional activity there.
- Supply-chain interruptions, sole-source suppliers, manufacturing concentration, labor disruption, extreme weather, energy shortages, disease outbreaks, and geopolitical events could affect product availability and costs.
- Cybersecurity and information-technology incidents could disrupt manufacturing, logistics, financial reporting, payments, and customer or consumer data.
- The Gillette indefinite-lived intangible asset had a $14.1 billion carrying value and only an approximately 5% fair-value cushion at the December 31, 2022 impairment test. Management identified it as particularly susceptible to future impairment from weaker demand, currency devaluation, inflation, recession, or further Russia-related reductions. No impairment was recorded in fiscal 2023.
- The company has ongoing tax audits and uncertain tax positions. The filing identifies approximately $354 million of uncertain tax positions that could affect future effective tax rates depending on resolution.
- Management states that pending litigation, environmental matters, guarantees, and off-balance-sheet arrangements are not expected to have a material effect, although outcomes remain uncertain.
Investor Verification Priorities
- Verify whether pricing-led growth can translate into volume stabilization or recovery, particularly in Europe, North America, Greater China, and Grooming.
- Reconcile reported sales growth with organic growth, foreign exchange, pricing, mix, acquisitions, and unit-volume changes.
- Monitor gross-margin sustainability as commodity costs, labor costs, foreign exchange, and promotional spending evolve.
- Review short-term debt maturities, commercial-paper reliance, refinancing costs, and the impact of higher interest rates on cash flow.
- Track the supply-chain-finance balance of approximately $6 billion and any changes in supplier payment terms or participation.
- Assess impairment sensitivity for the Gillette brand and other goodwill or indefinite-lived intangible assets.
- Review fiscal 2024 guidance when issued, including assumptions for organic sales, EPS, foreign exchange, commodities, taxes, capital spending, dividends, and share repurchases.